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Cover: Figure 7. M ethod of bimanual vitrectomy. 
An irrigation cannula provides irrigation through 
the paracentesis. Vitrectomy is performed deep to 
the posterior capsular tear to draw vitreous back 
without enlarging the tear.
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L e a rn in g  O b je c t iv e s
The study of this Focal Points module will 
help the reader to:
• Identify predisposing factors for posterior 
capsular rupture and where possible correct 
them
• Identify and treat the various causes of the 
intraoperative shallow anterior chamber
• Gain a greater degree of proficiency in deal­
ing with capsular tears and nuclear pieces 
during phacoemulsification and conversion 
to extracapsular cataract extraction (ECCE)
• Describe the principles of performing biman­
ual vitrectomy
• Initiate postoperative treatment in cases of 
torn posterior capsule and vitrectomy
Key W ords: capsulorrhexis complications, 
phacoemulsification, posterior capsular tears, 
shallow anterior chamber, suprachoroidal 
hemorrhage, vitrectomy
In tro d u c t io n
Modern cataract surgery performed with phacoemul­
sification allows meticulous intraocular control and 
minimal incision size, but has the inherent risk of cap­
sular rupture. Therefore, surgeons performing cataract 
surgery will inevitably face the complication of a torn 
posterior capsule. Torn posterior capsules are report­
ed to occur in 0.3% -6%  of cases. Faced with this 
complication, it is best for a surgeon to approach its 
management with the same systematic analytical and 
objective evaluation that would be applied to any 
surgery. Keep in mind that “great opportunity is usu­
ally disguised as an unsolvable problem.” Proper res­
olution will then provide the patient with the best sur­
gical, and therefore the best visual, outcome.
G e n e ra l  P re d is p o s in g  F a c to r s
Significant factors that may lead to a torn posterior 
capsule are listed in Table 1. The first of these factors 
is poor visibility, which may be caused by either phys­
ical problems or pathology. Physical problems that 
may lead to poor visibility include the relationship of 
the surgeon’s hand position to the patient s brow,
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Table I . G en era l P red isp osing  F actors for th e
Torn P o ster io r  C ap su le
Significant F acto rs
P oor visibility:
Secondary  to  physical p rob lem s:
h a n d  p o sitio n , deep-set brow , fluid poo ling , 
g lobe to rs io n
S econdary  to  path o lo g y :
dense arcus sen ilus, p te ryg ia , F u ch ’s co rnea l 
dystrophy , b a n d  k era to p a th y , co rn ea l scars, 
in te rs titia l k e ra titis
L ong an d  sh o rt ax ia l len g th  eyes
P seudoex fo lia tion
C a ta rac ts :
“B lack”
“W h ite ”
P o ste rio r p o la r  (calcified)
D ense as te ro id  hyalosis 
Sm all pup ils  
A d d itio n a l F acto rs 
P revious trau m a
(unseen cap su la r ru p tu re  o r zo n u la r dam age)
In ad e q u a te  m icroscope illu m in a tio n  o r a lignm en t
E q u ip m en t m a lfu n c tio n
Inexperienced  su rgeons
D em en ted , d iso rien ted , o r  an x io u s pa tien ts  
( in ad v e rten t m o v em en t d u rin g  p rocedu re )
pooling of irrigation fluid, and torsion of the globe. If 
the brow is prominent (i.e., a deep-set eye), for exam­
ple, a temporal rather than a superior approach will 
Minimize inferior torsion of the globe. If there is pool­
ing of fluid, turning the head temporally will allow 
fluid to drain. The use of an open-bladed speculum 
that allows easy access to the globe and will not im­
pede phacoemulsification cannot be underestimated. 
Although it may be preferable to operate in the axis of 
plus cylinder, this cannot be done when the plus cylin­
der is at 90° in the presence of a large brow and deep- 
set eye. The surgeon is wiser to forego the issue of 
astigmatism and operate temporally for access and 
exposure rather than risk a capsular tear.
Poor visibility can also be caused by pathology such 
as dense arcus senilus, dense nasal or temporal ptery-
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gia, severe Fuch’s corneal dystrophy with or without 
associated corneal edema, band keratopathy, old 
corneal scars, and interstitial keratitis. Faced with 
these challenges to visualization, the surgeon can do 
nothing but slow down, pay more attention to detail 
and visualization, and be more careful about focusing 
(slow the microscope focus speed) through the corneal 
problem to allow visualization of the anterior seg­
ment.
Patients with long or short axial length eyes, with 
the associated deep or shallow anterior chambers, also 
have predisposing factors for torn capsules. In high 
myopia, the anterior chamber is deeper, with more 
trampolening of the posterior capsule due to the thin­
ner, more resilient tissues. Eyes that have undergone 
previous vitrectomy behave in a similar manner. Dur­
ing phacoemulsification, lowering the infusion bottle 
lessens this tendency. In high hyperopia, the anterior 
chamber is crowded, making the posterior capsule clos­
er to the area of phacoemulsification, increasing the risk 
of a torn capsule. In this situation the early use of 
pulsed or burst phacoemulsification will help to deepen 
the anterior chamber. Other causes of the shallow ante­
rior chamber are considered later in this article.
Pseudoexfoliation is known to cause weak zonules 
and poor pupillary dilation secondary to fibrosis of 
the pupillary sphincter. These problems lead to an 
increased incidence of torn posterior capsules or de­
hiscence of the zonules.
Markedly brunescent or “black” cataracts as well 
as mature or “white” cataracts make capsulorrhexis 
more difficult. In the presence of an inadequate cap­
sulorrhexis and a hard cataract, the chance of tearing 
the capsulorrhexis peripherally increases significantly. 
Sam Masket, M .D ., has proposed using a retinal light 
probe held near the limbus to provide “side light” 
while lowering the microscope and room illumina­
tion. This allows the surgeon to better visualize the 
tearing edge of the capsule during capsulorrhexis, 
improving successful completion in these difficult sit­
uations. Other potential solutions include staining the 
anterior capsule with indocyanine green. To do this, 
dissolve 25 mg of indocyanine green dye in 0.5 mL 
aqueous solvent, then add 4.5 mL balanced saline 
solution (BSS Plus). The resulting solution will have a 
concentration of 0.5% and an osmolarity of 270 
mOsm. With a TB syringe, inject 0.1 cc of this solu­
tion under an air bubble in the anterior chamber, and 
then wash out the stain and air. The resulting stained 
anterior capsule will be readily visualized. Methylene 
blue can be used in a similar fashion, although toxic­
ity studies have not yet been performed with this dye.
In addition, posterior polar cataracts (especially
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Figure I .T h e  use of the Beehler pupil d ilator. T he barre l of 
the in s tru m en t is ro ta te d  so th a t the h o o k  is la tera l as it is 
passed  th ro u g h  the  w o u n d . It is then  ro ta te d  fu rth e r so th a t 
the  h o o k  is p o ste rio r an d  engages the sub jacen t iris. The 
th ree  long p rongs are th e n  ex tended  to  create m ultip le  
m icrosph inctero tom ies an d  so dilate the iris (inset su rgeon  s 
view).
those that are calcified) are also a predisposing factor. 
This is due to an increased incidence of posterior cap­
sular defects attributable to adherence of the cataract 
to the posterior capsule.
Dense asteroid hyalosis may make it difficult to 
visualize the posterior capsule during phacoemulsifi­
cation. The surgeon must again use due caution, and 
if necessary viscoelastics, to stay away from the pos­
terior capsule, thus avoiding inadvertent tears.
Small pupils are the final significant factor that may 
result in capsular tearing. Many regimens can provide 
adequate pharmacologic dilation in all patients. One 
recommended guideline is cyclopentolate hydrochlo­
ride (Cyclogel) 1%, phenylephrine (Neo-Synephrine) 
2.5% , and a nonsteroidal anti-inflammatory such as 
ketorolac tromethamine (Acular) 0.5% given every 5 
minutes for four doses prior to surgery. In those pat­
ients whose pupils have not dilated adequately, an 
additional dose of phenylephrine 10% gel is applied. 
Phenylephrine 10% solution is avoided, as recalci­
trant cardiac arrhythmias have been reported in 
patients receiving this medication.
If the pupil does not dilate enough for the surgeon 
to safely perform phacoemulsification, or even to con­
vert to ECCE, the surgeon is obligated to dilate it fur­
ther surgically. This can be accomplished by stretching 
with iris hooks, using a pupil dilator such as the 
Beehler dilator made by Moria (see Figure 1), per­
forming multiple sphincterotomies with microscissors,
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Figure 2. The use of an  iris re trac to r, th is one m ade by 
G rieshaber. F our 1-m m  paracentesis incisions are created  
parallel to  the iris a t the lim bus. T he hoo k s are  then  in tro ­
duced  and  positioned  to  engage the iris. T he hooks are 
tigh tened  m oderately  to  c reate  a 6 -7  m m  square  pupil 
(inset su rgeon’s view). A fter the  p rocedu re , th e  hoo k s are 
pushed  fo rw ard  to  release the iris.
using iris retractors (see Figure 2), or using a pupil 
expander such as that made by Grieshaber.
Additional predisposing factors to complications 
could include the following: pre-existing trauma with 
unseen capsular rupture or zonular damage; poor 
microscope alignment or illumination; equipment 
malfunction; inexperienced surgeons; or demented, 
disoriented, ojr anxious patients with subsequent inad­
vertent patient movement. These additional predis­
posing factors are also listed in Table 1.
In tr a o p e r a t iv e  C o m p lic a t io n s
Inadequate Capsulorrhexis
Capsulorrhexis may be too small, too large, or non- 
continuous. If the capsulorrhexis is too small in rela­
tion to the maturity and size of the cataract, a zonu- 
lolysis (tearing or destruction of zonules while the 
capsular bag remains intact) may be created. This is 
accomplished either by catching the subincisional cap­
sule with the phacoemulsification tip or by pulling on 
the capsule with aspiration opposite the incision. Re­
moval of subincisional cortex may be considerably 
more difficult than with adequate capsulorrhexis. The 
additional instrument manipulation may be an ante­
cedent to zonular disruption. During hydrodissection 
(the separation of the cortex from adjacent cortex or 
from the capsular bag), resistance to flow created by
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Figure 3. P osterio r p ressu re  causes the  capsu lo rrhex is to 
ex tend  periphera lly  in to  the zonules. N o te  the presence of 
po ste rio r pressure by th e  an te rio r d isp lacem ent o f the iris 
(inset su rg eo n ’s view).
the small capsulorrhexis may lead to fluid accumula­
tion deep to the nucleus and so may precipitate a pos­
terior capsular tear. In contrast, a large capsulorrhex­
is may incorporate zonules, predisposing the proce­
dure to causing zonular dehiscence.
Noncontinuous capsulorrhexis occurs when the tear 
inadvertently extends peripherally into the zonules 
(see Figure 3), under the iris, and can no longer be 
visualized. Once this occurs, the surgeon must deter­
mine the reason for the extension. It is most often 
caused by positive posterior pressure pushing the lens 
nucleus anteriorly. This creates vector forces on the 
tearing capsular bag, causing it to tear outward. In 
order to correct the situation, the speculum must be 
loosened, drape pressure must be relieved, and the 
anterior chamber should be refilled with a viscoelastic 
(preferably a dispersive one). The objective is to sub­
stantially deepen the anterior chamber, which then 
pushes the lens nucleus posteriorly, flattening its ante­
rior surface and thus diminishing the anterior pressure 
on the capsule.
Once all this has been done, the next step is to 
complete the tear. If the tear can be visualized, it can 
be completed by pulling the tearing capsule directly to 
the center of the pupil, redirecting the tear vector 
away from the periphery. This will maintain a contin­
uous capsulotomy. If the tear cannot be visualized, it 
must by completed from the opposite direction. This 
can be facilitated by deepening the anterior chamber 
with viscoelastics (see Figure 4). When the capsulor­
rhexis is completed, it should be made large enough to 
allow prolapse of the lens nucleus. Because this has
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Figure 4. Deepening the anterior chamber with viscoelast­
ic allows the capsulorrhexis to be completed from the 
opposite side. N ote the iris is now flat (inset surgeon s 
view), indicating that the anterior chamber is adequately 
filled with viscoelastic.
created a noncontinuous capsulorrhexis, the nucleus 
should be prolapsed into the anterior chamber and 
phacoemulsified there. Additional viscoelastic should 
be placed above the lens to protect the endothelium. 
No pressure should be exerted on the posterior cap­
sule, as this might cause the capsulorrhexis tear to 
extend peripherally around the equator into the pos­
terior nucleus. This type of extension can lead to vit­
reous loss or a dropped nucleus.
Nucleus Rotation Problems
Modern phacoemulsification techniques require free 
rotation of the lens nucleus in order to reach all of the 
nuclear material. If the surgeon does not lyse equato­
rial nuclear-cortical bag connections, nuclear rotation 
will be impeded. This then will require the surgeon to 
apply excessive rotational effort, during which zonu­
lar or capsular tears may occur.
When the lens nucleus will not rotate, the surgeon 
should perform additional hydrodissection in four 
quadrants. Gentle retropulsion of the nucleus will 
help to force fluid trapped behind the posterior pole of 
the nucleus around the equator, causing nuclear corti­
cal connections at the equator to lyse. If the lens 
nucleus still does not rotate freely, the surgeon can 
perform a two-handed rotational maneuver under vis­
coelastic. A lens manipulator is placed through the 
paracentesis-and across the nucleus to the opposite 
side. The phacoemulsification tip is then placed in the 
eye and into position, engaging the nucleus opposite
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the manipulator. In footpedal position 0, when there 
is no inflow, outflow, or phaco power, the vitreous will 
support the lens nucleus, and both instruments are 
gently rotated in unison.
A nterior Cham ber Shallowing
If, during the surgery, the surgeon finds it difficult to 
maintain the depth of the anterior chamber, the likeli­
hood of a torn posterior capsule increases. It is diffi­
cult to perform phacoemulsification in the presence of 
a shallow anterior chamber, as forward movement of, 
or significant pressure on, the posterior capsule may 
result in capsular rupture. In this situation, the sur­
geon must determine the cause for the shallow anteri­
or chamber. Causes for shallow anterior chamber in­
clude excessive fluid outflow or inadequate inflow, and 
positive posterior pressure.
Excessive Fluid Outflow/Inadequate Inflow. If excessive 
outflow is being caused by faulty wound construction 
in addition to excessive inflow due to the height of the 
infusion bottle, the bottle should be lowered and the 
wound sutured appropriately. If fluid inflow is inade­
quate, the incision should be enlarged or the infusion 
bottle raised. This situation may also be caused by an 
obstructed phaco tip sleeve. Sometimes the use of a 
dispersive rather than a cohesive viscoelastic may help 
to minimize these causes of chamber shallowing.
Posterior Positive Pressure. If fluid inflow and outflow 
are appropriate, but the anterior chamber remains 
shallow, a posterior positive pressure cause should be 
suspected. Posterior pressure is caused by external 
physical forces such as a tight speculum or drapes, a 
retrobulbar hemorrhage, or internal physical forces such 
as fluid misdirection syndrome, or suprachoroidal 
effusion or hemorrhage.
If the surgeon eliminates physical forces and retro­
bulbar hemorrhage as causes, and the chamber remains 
shallow, either fluid misdirection or a suprachoroidal 
effusion is developing. The surgeon can confirm this 
by placing a finger on the patient’s eye and sensing a 
firm globe with elevated pressure.
Fluid misdirection syndrome occurs when irrigat­
ing fluid passes through intact zonules or a zonular 
tear into the vitreous. This causes vitreous hydration, 
expansion of vitreous volume, and subsequent elevat­
ed posterior segment pressure. Fluid misdirection will 
usually respond to the treatment described below and 
allow the surgeon to cautiously proceed.
The treatment would include (1) lowering the infu­
sion bottle to decrease fluid inflow, (2) giving acetazol- 
amide (Diamox) (500 mg IV  push) and/or mannitol
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(Osmitrol) (1-2 g/kg 0.25% solution) intravenously, 
and (3) waiting approximately 20 minutes for both 
drugs to take effect, for the eye to stabilize and soften, 
and for the chamber to deepen.
If after this treatment the globe remains firm and the 
chamber shallow, a suprachoroidal effusion should be 
suspected. An indirect ophthalmoscopic evaluation or 
the use of an Osher Emergency Lens to view the pos­
terior segment may reveal an elevated choroidal mass.
Suprachoroidal effusion is caused by rupture of the 
short posterior ciliary vessels, with subsequent out­
pouring of plasma and blood into the suprachoroidal 
space. The amount of extravasated material is limited 
by the increased intraocular pressure created by this 
process, which effectively tamponades continued hem­
orrhage. If the wound is opened, the resultant hypo- 
tony allows continued hemorrhage and eventual ex­
pulsion of intraocular contents. Suprachoroidal effu­
sion will often be unresponsive to the treatment just 
described, with persistent high intraocular pressure 
and the resultant markedly shallow anterior chamber. 
In this situation it is best to interrupt the surgery, and 
return within the next 1—2 weeks to complete the sur­
gical procedure. Under no circumstance should the 
surgeon attempt to convert the procedure to ECCE, as 
enlargement o f the wound w ill destabilize the eye and 
allow a suprachoroidal effusion to become hemor­
rhagic, with subsequent expulsive hemorrhage.
T o rn  P o s te r io r  C a p s u le
During phacoemulsification, a number of factors may 
lead to tears in the posterior capsule. For example, the 
phaco tip may capture and tear the posterior capsule. 
In addition, turning 30° and 45° phaco tips bevel 
down so that aspiration can be applied at the same 
time as phacoemulsification power can aspirate and 
tear the posterior capsule. If hydrodelineation (the 
separation of endonucleus from the epinucleus) is 
inadequate, the resultant nuclear fragments adhere to 
the lens cortex. This forces the surgeon to perform 
phacoemulsification further toward the equator, 
beyond the hydrodelineation line, which may lead to 
equatorial tears. Similarly, inadequate hydrodissection 
resulting in cortex adhering to the posterior capsule 
may cause capsular tears during irrigation and aspira­
tion. Finally, it is possible, although debatable, that 
the sharp edges of a hard nucleus may tear the poste­
rior capsule.
These problems can be avoided with the use of sev­
eral strategies. These are (1) performing an adequate 
hydrodissection and hydrodelineation; (2) mobilizing
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1. S udden  deepening  o f the  a n te r io r  cham ber
2. M o m e n ta ry  p u p illa ry  d ila ta tio n
3. N ucleus falls aw ay  fro m  an d  w ill n o t com e 
to w a rd  the  p h aco  tip
4. V itreous a sp ira tio n  in to  ph aco  tip
Table 2. Four Cardinal S igns o f  a
Torn P o ste rior C ap su le______
the nucleus; (3) selecting 0° and 15° phaco tips; (4) 
using machines with surge protection software to pre­
vent trampolening and capture of the posterior cap­
sule; and (5) either using bimanual irrigation and aspi­
ration or performing irrigation and aspiration after 
the IOL insertion so that the lens holds the posterior 
capsule back, making it easier to remove difficult cor­
tex adhesions.
Recognition
The surgeon can recognize a torn posterior capsule by 
being alert for the four cardinal signs, as listed in 
Table 2. The first sign is sudden deepening of the ante­
rior chamber, occuring instantaneously as a tear 
appears in the capsule. It happens because the ham­
mocklike posterior capsular support is lost, causing 
the nucleus to begin to fall back. The second sign is 
that as the chamber deepens, the pupil will momen­
tarily dilate. The third sign occurs during phacoemul­
sification, when the nucleus falls away from, and will 
not come toward, the phaco tip because the flow 
dynamics in the anterior chamber have been altered 
by the tear in the posterior capsule. The fourth sign is 
that sometimes vitreous will be preferentially aspirat­
ed to the phaco tip, literally pushing the nucleus away.
Management
The posterior capsule can tear during hydrodissection, 
rotation, cracking, removal of the last nuclear frag­
ments, irrigation and aspiration, capsular polishing, 
lens insertion, or viscoelastic removal. The manage­
ment of the torn posterior capsule depends on the 
point in the procedure at which the tear occurs and 
the amount and density of the remaining lens nucleus.
Whenever the surgeon recognizes a tear in the pos­
terior capsule, successful management requires that 
two questions be answered: First, is there vitreous pres­
ent in the anterior chamber? Second, is conversion to 
a standard ECCE procedure indicated?
If no vitreous is present in the anterior chamber, 
dispersive viscoelastic may be used deep to the nucle-
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us to isolate the vitreous face and stabilize the nucle- j 
us. V iscoelastic can also be used above the nucleus to  | 
protect the endothelium . Phacoem ulsification can then  
usually be continued , fo llow in g  the principles enu­
m erated for capsular tears during capsulorrhexis.
Although in most cases phacoemulsification can 
continue after a posterior capsular tear, when in doubt, 
it is prudent to convert to an ECCE rather than pro­
ceed with phacoemulsification. The consequences of 
an inappropriate decision could be the loss of some or 
all of the nucleus into the vitreous.
The decision to convert a procedure to ECCE may 
depend on multiple factors, including the hardness 
and size of the nuclear material in the anterior seg­
ment, the size of the pupil, the ability to maintain an 
adequately deep anterior chamber, ease of access to 
the anterior segment, and the perceived severity of the 
posterior capsular tear. The decision should also be 
based upon the surgeon’s level of experience.
A key factor in this decision would be the presence 
of vitreous in the anterior chamber combined with a 
large piece of nucleus. If vitreous is present immedi 
ately after a capsular tear, this generally indicates a 
large capsular tear combined with syneretic poor vit­
reous support. The potential gravity of this situation 
would favor conversion to ECCE.
While considering the situation, the surgeon should 
be careful not to depressurize the anterior chamber by 
abruptly removing the phaco tip. The resultant sud­
den loss of anterior chamber fluid and pressure will 
allow the positive vitreous pressure to push the poste­
rior capsule forward. The tear will enlarge, frequently 
the vitreous face will rupture, and vitreous will pass 
into the anterior chamber. To prevent this, the surgeon 
should pressurize the anterior chamber with visco­
elastic before removing the phaco tip.
Conversion to EC CE. A general method of converting 
the phacoemulsification procedure to ECCE is out­
lined in Figure 5. An important preparatory step is to 
immediately secure the lens nucleus with a dispersive 
viscoelastic to prevent the loss of nuclear fragments 
into the vitreous. To do this, viscoelastic is injected 
underneath the nucleus to support it. Creating a para­
centesis opposite the incision may be necessary to 
allow passage of a hook into the superior anterior 
chamber. This hook can be used to loosen and manip­
ulate nuclear material embedded within the superior 
capsular bag into the anterior chamber, where it can 
be secured for later extracapsular extraction.
If a clear c'orneal incision is used, it may be sutured 
and abandoned (see Figure 5a). If a sclerocorneal 
(frown) incision has been used, it can be extended as
Figure 5. C onverting  phacoem ulsification  to  ECCE. 5a: 
C lear co rnea l incision is su tu red  and  ex tracap su la r incision 
is created . 5b: F ro w n  incision  is ex tended . 5c. Side view  of 
ex trac tio n  o f  nuclear pieces w ith  lens loop  and  second 
in strum en t, ex trud ing  nucleus th ro u g h  incision. 5d: Sur­
geon ’s view  o f p rocedu re  in  5c. 5e: M e th o d  of su turing.
demonstrated in Figure 5b. A well-constructed shelved 
limbal incision is created after appropriate conjuncti­
val peritomy and cautery. The size of this incision 
depends on the size of the nuclear fragment in the 
anterior chamber. In general, the incision should be 
larger than the surgeon thinks is necessary for extrac­
tion of the nuclear remnant. Once the incision has 
been created, the wound is opened fully and then a 
lens loop and secondary lens manipulator are used to 
extrude the lens nucleus (see Figure 5c, side view, and 
Figure 5d, surgeon’s view). Do not apply external 
pressure to the opposite limbus, as vitreous will be 
preferentially expelled.
Alternatively, the clear corneal incision can be en­
larged for extracapsular extrusion of nuclear material 
and implantation of a PMMA or foldable IOL. The 
choice of lens implant depends on the amount of 
residual anterior capsule. Once the lens nucleus has 
been removed, anterior segment surgery should pro­
ceed as described below. The enlarged clear corneal or 
limbal incision is first sutured with interrupted or run­
ning 10-0 nylon radial sutures that are trimmed on the 
knot and buried (see Figure 5e).
Continuing Phacoemulsification. If the surgeon thinks 
that continued phacoemulsification is appropriate, a 
dispersive viscoelastic should be placed below the lens 
nucleus to raise and secure it in the anterior chamber. 
Infusion bottle height, vacuum, and flow should be 
lowered to create a low-flow system, e.g., if using high 
flow and vacuum the bottle is lowered from 65 mm to
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55 mm, flow decreased to 18 cc/min and vacuum to 
100 mm Hg. The nucleus is then emulsified in the 
anterior chamber in one piece using two instruments. 
The second instrument is used to feed the edges of the 
nucleus into the phaco tip, applying power in foot- 
pedal position 3 only when nucleus is adjacent to the 
phaco tip so as not to emulsify vitreous, which might 
be aspirated preferentially (see Figure 6 inset). It is 
best not to create multiple fragments of nucleus by 
cracking or other maneuvers, as these fragments are 
difficult to follow and may fall through the posterior 
chamber tear into the posterior segment.
If the tear seems too large to support continued 
phacoemulsification but small-incision surgery is de­
sired, the surgeon can create a pseudoposterior cap­
sule using a Sheets glide (see Figure 6). The Sheets 
glide must first be cut down to the appropriate size in 
relationship to the incision size. It is then placed 
through the incision into an anterior chamber well- 
filled with viscoelastic. The glide is manipulated be­
hind the nuclear fragment (a second instrument may 
be helpful) and, if possible, into the opposite ciliary 
sulcus. The surgeon then performs phacoemulsifica­
tion over the Sheets glide. The incision may need to be 
enlarged slightly to make room for both the phaco tip 
and the Sheets glide. The glide can be left in place dur­
ing phacoemulsification of the remaining nucleus, as 
well as during irrigation and aspiration of any resid­
ual cortex.
If the capsular tear occurs when only a small frag­
ment of nucleus remains, the fragment can be emulsi­
fied by moving it near the phaco tip and then apply­
ing aspiration and phacoemulsification power. This 
will immediately engage the nuclear fragment in the 
phaco tip, thus preventing the aspiration of vitreous.
Irrigation and Aspiration of Cortex. To remove cortex 
in the presence of a capsular tear, the remaining cor­
tex should be stripped toward the tear. The 0.3 mm 
irrigation and aspiration tip should be embedded into 
the cortex before vacuum is applied so as not to aspi­
rate vitreous. Lowering the infusion bottle will 
decrease fluid inflow and the resultant turbulence, 
which might enlarge the capsular tear or force more 
vitreous forward. The surgeon should try to avoid 
working directly over the capsular tear and never strip 
cortex directly away from the tear, as this will imme­
diately enlarge it. If necessary, the surgeon can remove 
cortex manually. If cortex is difficult to remove and 
not too voluminous, it should be left behind.
Figure 6. Sheets glide in position to form pseudoposterior 
capsule. N ote how it supports the nucleus for continued 
phacoemulsification. The inset shows how the nucleus, sec­
ured from falling into the vitreous by viscoelastic, is then 
pushed until it is in contact with the phaco tip. Aspiration 
and phacoemulsification power may now be applied.
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Vitrectomy for Vitreous in A nterior Chamber
If vitreous is present in the anterior chamber immedi­
ately after the capsular tear, it should not be removed 
until after the nucleus or nuclear fragments are emul­
sified, as it might provide support to keep the nucleus 
from falling posteriorally. Once phacoemulsification is 
completed, the surgeon should perform a bimanual 
vitrectomy. This is accomplished by establishing irri­
gation through a 23-gauge cannula placed through the 
paracentesis. The infusion bottle is positioned at the 
appropriate height to maintain the anterior chamber 
during vitrectomy. A guillotine-type vitrector (with the 
irrigating sleeve removed) is then placed through the 
incision and through the posterior capsular tear to 
draw vitreous back through the tear into the posteri­
or segment. The surgeon then performs the vitrectomy 
using a high cutting rate, i.e., 400 or 450 cuts per 
minute, and a flow of 200 cc/min with a vacuum of 
100 mm Hg. The vitrectomy is continued until no vit­
reous is present anterior to the plane of the posterior 
capsule. Bimanual vitrectomy is preferred because it 
may prevent the capsular tear from enlarging (see Fig­
ure 7, cover).
If the capsular tear is small and only a small amount 
of vitreous is present, the surgeon can perform a dry 
vitrectomy. In this case, the anterior chamber is filled 
with a dispersive viscoelastic. Then the guillotine-type 
vitrector (with no irrigation sleeve) is placed through
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the tear into the posterior capsule and into the vitre­
ous. A  small vitrectomy is performed using the para­
meters noted above. No irrigation is necessary, but the 
viscoelastic volume may be augmented as needed.
In certain situations, the nucleus cannot be stabi­
lized. This is most likely to occur when the phaco tip 
creates a large zonular dehiscence opposite the inci­
sion. In such a circumstance zonules are present sub- 
incisionally, so that the distal pole of the nucleus falls 
into the vitreous but the nucleus remains attached 
subincisionally, preventing the entire nucleus from dis­
appearing. In this unique setting, the surgeon should 
make a stab incision into the pars plana 3.5 mm pos­
terior to the incisional limbus. Alternatively, the pars 
plana incision can be moved to wherever the zonular 
hinge occurs. As described by Charles Kelman, M .D., 
a cyclodialysis spatula is then used to lever the nucle­
us into the anterior chamber through the pars plana 
approach. Once the nucleus is secured within the 
anterior chamber, it can be removed either by phaco­
emulsification or preferentially by extruding it through 
an extracapsular incision (see Figure 8).
In all cases, if the posterior capsular tear is entirely 
within view, the surgeon can attempt a posterior cap­
sulorrhexis. If the vitreous face is intact, this is done 
by placing viscoelastic above and below the tear and 
pushing the vitreous face back, allowing room to 
grasp the torn capsule. If the vitreous face is already 
broken, viscoelastic is necessary only to stabilize the 
anterior chamber and make room for the forceps. 
Using a capsulorrhexis forceps, the surgeon gently 
tears the capsule to create a 360° posterior capsulor­
rhexis. As the posterior capsule is more fragile than 
the anterior capsule, frequent regrasping of the tearing 
capsular flap is necessary to provide adequate control 
of the direction of the tear. A Masket modified Utrata 
Forceps is particularly useful for this procedure, as the 
curved blades allow easier access to the anatomically 
posterior capsular flap. The surgeon may encounter 
difficulty with visibility of the tearing capsule, and 
with forceps manipulation deep in the anterior cham­
ber. Failed attempts may result in extension of the tear 
and, if not already present, vitreous loss.
Lost Nucleus o r Nuclear Fragments
When the posterior capsule is torn during phacoemul­
sification, small pieces of nucleus or cortex may fall 
into the vitreous. If the pieces are soft and more corti­
cal in nature, they will usually resorb with little seque­
lae. If the piece of material is large (including the 
entire nucleus) or hard, the likelihood of vitritis with 
subsequent macular edema and/or secondary glauco­
ma is high. If vitritis or elevated IOP occurs, the frag-
Figure 8. Before v itrectom y, a cyclodialysis spa tu la  is used 
to  lever a h inged  nucleus in to  the  an te rio r  cham ber (Kel­
m an  technique).
ments should be retrieved within 2 weeks of the orig­
inal surgery. To remove intravitreal nuclear fragments, 
a pars plana approach, vitrectomy, and fragmatome 
removal of the nucleus is recommended. Therefore, 
the lens implant can usually be placed into the ciliary 
sulcus at the time of the primary surgery.
Zonular Dialysis
Zonular dialysis greatly increases the risk of both vit­
reous loss and nuclear fragments dislocating into the 
vitreous. Obviously, IOL implantation may be more 
difficult. The surgeon needs to evaluate the number of 
clock hours involved with the zonular dialysis and 
consider his or her experience performing phacoemul­
sification in this setting. The intracapsular ring and 
new viscoelastic techniques have increased the suc­
cessful outcome of phacoemulsification in these chal­
lenging situations.
Intracapsular PMMA capsular-tension ('Morcher) 
rings are placed within the capsular bag before pha­
coemulsification, using an injection instrument. They 
apply uniform pressure throughout the bag equator, 
discouraging its collapse during phacoemulsification 
and irrigation and aspiration. They also support the 
bag internally, decreasing the risk of spreading zonu­
lar loss. See Suggested Viewing for more detailed 
information.
Postoperative Care
In the case of complications, the surgeon should con­
sider adding subconjunctival triamcinolone (Kenalog)
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Table 3. C o m p lica tio n s A fter  C a ta ra ct Surgery: V arious Surgeons* E xperien ce
V itrectom y % 
V ision > 20 /40
Osher-Cionni*
1.00%
8 9 .0 0 %
Fishkind**
1 .25%
8 0 .0 0 %
Powe et. a l.t
0 .8 0 %
9 0 .0 0 %
Early Complications
E n d o p h th a lm itis  
H yphem a 
V itreous in  AC 
E levated  IOP
0.00%
0.00%




5 .0 0 %
0.00%
0 .1 3 %  
0.20% 
N o t rep o rted  
0.20%
Late Complications
Cystoid. m acu la r edem a 
R etina l d e tachm en t
2.00%
0.00%
0 .2 7 %
0.10%
1 .50%
0 .7 0 %
1 Out of 4800 cataract extractions.
"■* Out of 1834 cataract extractions by phacoemulsification.
\  Out of 68,316 cataract extractions by phacoemulsification, extracapsular extraction, or intracapsular extraction.
20 mg to the usual topical medications. Prednisolone 
sodium acetate (Pred Forte) 1% and diclofenac sodi­
um (Voltaren) may be given in a q.i.d. or more fre­
quent dosage. A  subconjunctival triamcinalone injec­
tion may be repeated at 3 weeks after surgery if cystoid 
macular edema (CME) is diagnosed, and more frequent 
office visits are often required.
B rief C lin ical R ev iew
Posterior capsular tears worsen the prognosis for suc­
cessful visual outcome of cataract surgery. When the 
posterior capsule is violated but vitreous is not lost 
and a posterior chamber IOL is implanted in the cap­
sular bag or ciliary sulcus, there is increased risk of 
CME, vitreous prolapse into the anterior chamber, and 
retinal detachment. Intraoperative peripheral iridecto­
my may be necessary, increasing the risk of hyphema.
Vitreous loss appears to be the crucial factor influ­
encing clinical outcome. Once vitreous is lost, the post­
operative course is complicated in 30% of patients, 
with an increased number of visits due to hyphema, 
retained cortex, corneal edema, blurred vision, and 
vitreous strands. Long-term retinal problems include 
chronic CME, macular holes, and retinal detachment. 
These complications are shown in Table 3, which com­
pares postoperative outcomes for three representative 
surgeons.
C o n c lu s io n
Recognition and appropriate adjustment of the 
surgical plan in the presence of predisposing factors 
for a torn posterior capsule should help to decrease 
the incidence of this problem. Likewise, prompt 
recognition and treatment of torn capsules and vitre­
ous loss should help to minimize serious complica­
tions and improve surgical outcomes. Methodical analy­
sis of complications and appropriate treatment with 
nuclear and cortical fragment removal, preservation 
of as much posterior capsule as possible, careful vit­
rectomy, appropriate IOL selection and insertion, and 
postoperative modification of various medications will 
further improve the postoperative course.
W illiam  J. Fishkind, M.D., F .A .C .S ., is Clinical 
Professor of Ophthalmology, University of Utah, 
Salt Lake City, UT; and director of Fishkind and 
Bakewell Eye Care and Surgery Center, Tucson, 
AZ. Dr. Fishkind is a paid consultant to Allergan 
and Mentor.
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The Clinician’s Corner section is intended to provide 
additional viewpoints on the subject covered in this 
issue o f Focal Points. Consultants have been invited 
by the Editorial Review Board to respond to ques­
tions posed by the Academy’s Practicing Ophthal­
mologists Advisory Committee 
for Education. While the adviso­
ry committee reviews the mod­
ules,- consultants respond with­
out reading the module or one 
another’s responses.— Ed.
1. In what clinical circumstances 
would a pars plana vitrectomy 
be indicated over a limbal ante­
rior vitrectomy?
Dr. Crandall: Unless the surgeon 
is well-trained and comfortable 
with a pars plana approach in 
cataract surgery, there are prob­
ably few indications to use this approach. I will use 
it if I have had to do a Kelman’s posterior assisted 
levitation of the lens. I also do it in pediatric cases 
to remove the central posterior capsule. The classic 
indication would be to remove fallen lens frag­
ments. However, I would not ordinarily suggest 
anterior segment surgeons attempt this, as most are 
not comfortable with the three-part vitrectomy 
required to remove fallen lens fragments.
Dr. Davison: Vitreous is a normal resident of the 
posterior segment, while the lens is a normal resi­
dent of the anterior segment. When vitreous is 
found in the anterior segment, an anterior vitrecto­
my is the procedure of choice. When the lens or rel­
atively large lens fragments are found in the poste­
rior segment, then a pars plana vitrectomy is the 
procedure of choice.
I have had to employ emergency pars plana inci­
sions without pars plana vitrectomy during 
cataract surgery several times. In these cases the 
zonular apparatus was so weak that the lens start­
ed to fall posteriorly during phacoemulsification. 
To do this, I passed a massive vitreous retraction 
(MVR) blade through the pars plana 3.5 mm from 
the limbus to pry the sinking lens forward; with 
that successfully accomplished, I still finished with 
an anterior limbal vitrectomy. If a posterior vitrec­
tomy was performed, vitreous strands need to be 
trimmed from the pars plana incisions with West- 
cott scissors and the scleral and conjunctival inci­
sions closed with 8-0 Vicryl.
2. When a posterior capsule ruptures without vit­
reous prolapse, what technique do you employ to 
remove the remaining nuclear fragments?
Dr. Crandall: The first goal is to stabilize the sit­
uation. I usually use a dispersive 
viscoelastic to tamponade and 
hold the vitreous face back. If 
the remaining nuclear piece(s) 
are small enough, they can be 
brought up and removed manu­
ally with visco-elastic and then 
forceps. The rupture can be sta­
bilized and kept from expand­
ing by doing a continous tear 
capsulotomy.
If the piece of nucleus is large 
then it is brought up and the 
wound is enlarged by 0.5 mm to 
accommodate a Sheets phaco 
glide, which is placed under the 
nuclear remnant. The phacoemulsification unit is 
reintroduced with all parameters changed. The 
infusion bottle is lowered and the aspiration flow 
rate is reduced to 14, the vacuum to around 100 
(normal 400 mm Hg Alcon Legacy). The nuclear 
pieces are then slowly phacoemulsified.
Dr. Davison: Very small fragments may be left in 
the anterior vitreous. Larger ones may be removed 
with anterior vitrectomy. If larger nuclear frag­
ments have been forced posteriorly through the 
most anterior vitreous, a pars plana vitrectomy will 
be required. If the fragments are small or soft they 
may nibbled by the vitrector or forced bimanually 
into the vitrector opening. If the fragments are 
large or hard a fragmatome may be employed in 
the vitreous cavity center after vitreous removal. If 
this is unavailable, the fragments may be maneu­
vered into the anterior segment and removed by the 
Viscoat sandwich technique with a normal pha­
coemulsification tip. ,
Viscoat serves to isolate nuclear fragments in a 
kind of plastic gel. Phacoemulsification can then be 
used to remove the fragments. Viscoat may have to 
be reinjected several times in order to preserve 
appropriate anatomic relationships. It is important 
to have a relatively normal anterior chamber pre- 
sure and not over or underfill the anterior chamber.
If vitreous is encountered, instrumentation should 
be immediately changed to vitrectomy, strands cut, 
then Viscoat reinstilled to push remaining sheets
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and strands back so that phacoemulsification can 
continue.
Make sure to establish aspiration flow and infu­
sion inflows before applying phacoemulsification 
power. Circulating balanced salt solution (BSS) 
cools the incision surfaces— it is very easy to burn 
these surfaces instantaneously without adequate 
cooling. I have found it helpful to irrigate and aspi­
rate a central core of the Viscoat material prior to 
phacoemulsification. A stirring motion with a cy­
clodialysis spatula near the phacoemulsification tip 
will facilitate creation of a central BSS space. Ade­
quate vacuum and aspiration flow rate machine 
parameters must exist to aspirate Viscoat.
3. When a defect is present in the posterior capsule, 
should a silicone lens be placed in the sulcus if there 
is adequate support, or should the surgeon use 
PMMA or acrylic lenses?
Dr. Crandall: Silicone lenses have performed well 
over the years, but there are situations in which I 
would elect to use another material. For instance, I 
would choose alternate materials if the patient is 
diabetic or has a condition (i.e., myopic degenera­
tive retinal problems) that may require the poten­
tial use of silicone oil, and for patients with uveitis 
and possibly those with glaucoma. Also the sur­
geon should definitely use a silicone lens with 
PMMA haptics and not polypropylene when the 
lens will sit in the sulcus.
Usually I use a 6.00-mm acrylic lens for sulcus 
fixation. The lenses are large enough and “quiet,” 
i.e., they generally do not induce inflammation. 
The new heparin-coated PMMA lenses would be an 
excellent alternative.
Dr. Davison: Because patients with posterior cap­
sular defects may be at higher risk for detached 
retinas, they are at higher risk for pars plana vit­
rectomy and gas—fluid exchange. Because the pos­
terior optic surfaces of silicone lenses tend to fog, 
they should not be used if pars plana vitrectomy is 
anticipated.
That consideration aside, a 1-mm, punched-out, 
circular posterior capsular defect could accommo­
date the placement of any style of posterior cham­
ber IOL within the capsular bag. A larger 2-mm 
defect could accommodate an acrylic, PMMA, or 
three-piece silicone IOL within the capsular bag. If 
the posterior defect is larger but is still accompa­
nied by an intact anterior capsulorrhexis, any IOL 
except plate haptic silicone may be placed with its 
optic posterior to and captured by the capsulor­
rhexis with the haptics placed within the sulcus. 
The surgeon will need to subtract 0.5 diopters from 
the power of the selected IOL because it has been 
moved forward. If the posterior and anterior cap­
sules are both torn and the eye is relatively short, a 
PMMA, larger acrylic, or three-piece silicone lens 
can be placed in similar style with the haptics in the 
sulcus. If the eye is larger, any of these three styles 
could be used, but a McCannal-type suture, or 
preferably two, will be needed.
4. In what circumstances would you select an ante­
rior chamber lens, a sulcus-fixated lens, and a sut­
ured posterior chamber lens?
Dr. Crandall: My preference would be a sulcus-fix­
ated lens, which depends solely on enough capsular 
support. If this is not available, my next choice is 
an anterior chamber lens. The modern four-point 
flexible anterior chamber lenses have performed 
well. However, these cannot be used in certain sit­
uations, such as in eyes without irides (from trau­
ma or aniridia), small eyes, and eyes with peripher­
al anterior synechia (no available angle structures). 
In these cases an IOL is sutured into the posterior 
capsule. In general, however, the extra manipula­
tion this requires is not necessary.
Dr. Davison: If there were so little central capsule 
left that virtually no stabilization would be provid­
ed for an IOL optic or at least its midperipheral 
haptics, or if a segment of peripheral capsule and 
the accompanying zonular fibers were missing, I 
would place an anterior chamber lens. If there were 
enough capsule left, I would employ the method 
outlined in my answer to question 3. I would use 
Sulcus suture fixation only if capsular support was 
virtually nonexistent and if angle anomaly was sig­
nificant enough that an anterior chamber lens 
could not be placed.
5. Following vitrectomy and lens placement, what 
is the preferred technique for removing viscoelastic 
in the presence of a torn posterior capsule?
Dr. Crandall: Assuming that the lens is stable, 
sutures have been placed, and the iris has been con­
stricted with a miotic, the goal is to remove the vis­
coelastic without bringing more vitreous forward
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or displacing the lens. To reduce turbulence, the 
viscoelastic can be removed manually by exchang­
ing it with BSS. This is labor intensive, especially 
with dispersing viscoelastics. If the surgeon has 
used an anterior limbal vitrectomy probe, then it 
can be used again to remove the viscoelastic. I am 
usually not too aggressive in this situation; if the 
patient can tolerate it I will use a beta blocker and 
oral acetazolamide (Diamox) to keep the intraocu­
lar pressure from increasing too quickly.
Dr. Davison: The surest way to remove viscoelastic 
in this situation is to serially exchange it with BSS 
using two 3-cc syringes. One should be tipped with 
a 22- or 25-gauge cannula and the other with a 30- 
gauge cannula. The larger can be used to remove 
viscoelastic and the smaller to replace the removed 
volume with BSS. Make sure to keep the anterior 
chamber relatively pressurized and full. Viscoat is 
more difficult to adequately remove, but it is asso­
ciated with fewer high-pressure rises. Healon in its 
various preparations is easier to remove but more 
prone to pressure elevation if significant amounts 
are left in place.
6. What are your recommendations for observing 
or removing a retained lens fragment?
Dr. Crandall: Retained lens material may be found 
in a number of situations, but certainly even when 
surgery proceeded with no intraoperative compli­
cations. In this case, from 1-7 days after surgery, a 
small piece of nuclear material that was missed 
(hidden in the sulcus or angle) will become visible. 
If it is small enough and the eye is “quiet,” i.e., not 
irritated, the surgeon can observe and allow the eye 
to slowly remove it, as long as the eye does not 
become inflamed and the cornea tolerates it.
The most common situation, however, is in a 
complicated case where retained lens material falls 
posteriorly. If the material is cortical, it will swell 
and appear to enlarge. If the eye remains “quiet,” 
this material will resolve over weeks. If the materi­
al is nuclear and large, it will usually lead to inflam­
mation, and possibly chronic cystoid macular 
edema (CME). In this situation I believe referral to 
a retina/vitreous specialist is indicated for removal.
Dr. Davison: Anterior chamber lens fragments larg­
er than 0.3 mm in diameter should generally be 
removed, because they damage corneal endotheli­
um. If they find their way posterior and become
trapped within the zonular apparatus, they can be 
observed.
Vitreous cavity lens fragments 1.0 mm in diam­
eter or smaller can be observed and treated med­
ically for increased inflammation and intraocular 
pressure (IOP) if they occur. Seeing the fragment 
may trouble patients but it will usually be absorbed 
over time. Harder fragments will take longer to 
resolve than soft. Vitreous cavity fragments larger 
than 1.0 mm should probably be removed with 
pars plana vitrectomy.
7. What, if any, intracameral or subconjunctival 
medications do you employ? Do you alter this rou­
tine in the event of capsular rupture with vitreous 
loss?
Dr. Crandall: In general the only intracameral med­
ications I use are 1% unpreserved lidocaine (Xylo- 
caine) for anesthesia and acetylcholine (Miochol-E) 
or carbachol (Miostat) for cases in which the pupil 
needs to be constricted, such as in combined proce­
dures or capsular rupture. I do not use a miotic in
routine cases.
I do not use either subconjunctival antibiotics or 
steroids. I will use a collagen shield soaked in dex- 
amethasone phosphate (Decadron) and cefazolin 
(Ancef). If I suspect endophthalmitis, then I will use 
dexamethasone and vancomycin with ceftazidime 
after vitreous biopsy, but there is no evidence that 
using antibiotics in the line or in the anterior cham­
ber at the end of the procedure reduces the chance 
of endophthalmitis.
Dr. Davison: In 500-cc BSS infusion volume I use 
vancomycin 30 mg, and preservative-free epineph­
rine (Epifrin) 1 cc of 1/10,000.1 use no subconjunc­
tival medications. I would not alter these medications 
for capsular rupture. However, if surgery was diffi­
cult, I might give more topical steroids for a longer 
period than my usual prednisolone acetate (Pred 
Forte) 1% q.i.d. for 2 weeks then b.i.d. for 2 weeks.
Alan S. Crandall, M.D., is Professor of Ophthal­
mology, Clinical Track, University of Utah, Salt 
Lake City, Moran Eye Center.
James A. Davison, M.D., F.A.C.S., is a practicing 
ophthalmologist at the Wolfe Clinic, Marshalltown, 
LA.
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